BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Feature

Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation

What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...

March 14, 2025 | Interaction

AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia

Chronic kidney disease (CKD) is a growing public health challenge in Asia, affecting over 400 million people. In an insightful discussion with BioPharma AP...

March 12, 2025 | News

ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma

As the demand for plant-based and clean-label pharmaceutical solutions grows, ACG Capsules has positioned itself at the forefront of innovation with its ve...

March 06, 2025 | Interview

ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment

With obesity-related chronic diseases on the rise in Singapore, ORA Group has introduced a pioneering hybrid weight management model, blend...

February 19, 2025 | Expert Insight

Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development

In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...

January 10, 2025 | News

Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships

In an exclusive interview with BioPharma APAC, Ed Deng, Co-founder and CEO of Health2Sync, delves into the transformative impact of their collabora...

December 24, 2024 | Interaction

Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025

Antibody-Drug Conjugates (ADCs) represent a paradigm shift in oncology, offering targeted cancer treatment that minimizes collateral damage to healthy cell...

December 23, 2024 | News

Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership

The year 2024 has been a transformative year for the pharmaceutical, biopharma, and biotech industries. With a series of high-profile appointments, the yea...

December 20, 2024 | Analysis

25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility

Pioneering a Greener Future for Healthcare Innovation The biopharmaceutical industry is undergoing a transformative shift as environmental sustainability ...

December 17, 2024 | Report

India’s Biotech Boom: Supriya Kashikar on Startups, Innovation, and the Road to 2030

India’s biotechnology sector is on a trajectory to reach $300 billion by 2030, fueled by a dynamic startup ecosystem, robust government initiatives l...

December 17, 2024 | Interview

Driving Precision Medicine with AI: Tomasz Jetka, PhD, on Ardigen’s Vision for 2025

In an exclusive conversation with BioPharma APAC, Tomasz Jetka, PhD, Director of AI at Ardigen, delves into the company's ambitious plans to revolutionize ...

December 16, 2024 | Interview

Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness

In an exclusive interview with BioPharma APAC, Mr. Brendan O’Callaghan, Executive Vice President, Manufacturing & Supply at Sanofi, sheds light o...

December 09, 2024 | News

AstraZeneca's Drive to Transform Lung Cancer Care in LMICs

In an exclusive interview with BioPharma APAC, Ti Hwei How, Vice President of International Oncology & Market Access at AstraZeneca, sh...

December 02, 2024 | Interview

Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial

In an exclusive conversation with BioPharma APAC, Stefan Scheidl, VP and Global Head of Ophthalmology Medical Affairs at Roche, delves into the g...

December 02, 2024 | Interview

Stay Connected